Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2020 Feb;31(2):191-201.
doi: 10.1016/j.annonc.2019.10.026. Epub 2019 Dec 20.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

K Park  1 , J Vansteenkiste  2 , K H Lee  3 , G Pentheroudakis  4 , C Zhou  5 , K Prabhash  6 , T Seto  7 , P J Voon  8 , D S W Tan  9 , J C H Yang  10 , J Wang  11 , K Govind Babu  12 , Y Nakayama  13 , A Alip  14 , K L M Chua  15 , J C-H Cheng  16 , S Senan  17 , Y C Ahn  18 , T-Y Kim  19 , H K Ahn  20 , S Peters  21 , T Yoshino  22 , J-Y Douillard  23
Affiliations
Free article
Practice Guideline

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

K Park et al. Ann Oncol. 2020 Feb.
Free article

Abstract

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of early and locally-advanced non-small-cell lung cancer (NSCLC) was published in 2017, and covered the diagnosis, staging, management and treatment of both early stage I and II disease and locally-advanced stage III disease. At the ESMO Asia Meeting in November 2018, it was decided by both the ESMO and the Korean Society of Medical Oncology (KSMO) to convene a special face-to-face guidelines meeting in 2019 in Seoul. The aim was to adapt the ESMO 2017 guidelines to take into account potential differences related to ethnicity, cancer biology and standard practices associated with the treatment of locally-advanced, unresectable NSCLC in Asian patients. These guidelines represent the consensus opinions reached by those experts in the treatment of patients with lung cancer who represented the oncology societies of Korea (KSMO), China (CSCO), India (ISMPO), Japan (JSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence, and it was independent of both local current treatment practices and the treatment availability and reimbursement situations in the individual participating Asian countries.

Keywords: ESMO guidelines; NSCLC; Pan-Asian; consensus; locally-advanced; unresectable.

PubMed Disclaimer

Publication types